The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy of tumor treatment field (TTF) therapy alone and in combination with chemotherapy in pancreatic cancer preclinical models.
Moshe Giladi
Employment or Leadership Position - Novocure
Rosa S. Schneiderman
Employment or Leadership Position - Novocure
Yaara Porat
Employment or Leadership Position - Novocure
Aviran Itzhaki
Employment or Leadership Position - Novocure
Daniel Mordechovich
Employment or Leadership Position - Novocure
Uri Weinberg
Employment or Leadership Position - Novocure
Yoram Palti
Consultant or Advisory Role - Novocure